Who invested in Verseau Therapeutics?
Verseau Therapeutics's investors include Alexandria Venture Investments, Highlight Capital and Yonghua Capital.
Who invested in Verseau Therapeutics
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2019, from 1 source
- Latest round
- Venture, $50MOct 2019
- Investors
- 3
The rounds
- Oct 2019
Founders and team
From the SEC filings it signed: 4 on the team.
- Christine BuntExecutive Officer, Directori
- Daniel AndersonExecutive Officer, Director, Promoteri
- Robert LangerDirector, Promoteri
- Walter CaponeExecutive Officeri
On the board, as filediJong Chang
Quick answers about Verseau Therapeutics
How much has Verseau Therapeutics raised?
Verseau Therapeutics has raised $50M across 1 round since 2019.
When did Verseau Therapeutics last raise?
Verseau Therapeutics's most recent round was a Venture of $50M in Oct 2019.
What was Verseau Therapeutics's biggest round?
Its most recent round, $50M in Oct 2019, is also its largest on record.
Who backed Verseau Therapeutics first?
Verseau Therapeutics's first round on record, in Oct 2019, was backed by Alexandria Venture Investments, Highlight Capital and Yonghua Capital.
What stage is Verseau Therapeutics at?
Verseau Therapeutics's latest named round is a Venture, in Oct 2019.
Companies like Verseau Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.